Table 2.
Comparison by chi-square test of reproductive outcomes and rates (%) of euploid, aneuploid and mosaic blastocysts, between male factor (MF) and non-male factor (NMF) groups
| MF (n = 173) (95%CI) | NMF (n = 146) (95%CI) | P value | |
|---|---|---|---|
| Implantation | 37/123 (30.1%) (23.2–36.9) | 24/68 (35.3%) (27.5–43.1) | NS |
| Clinical pregnancy | 34/118 (28.8%) (22.1–35.5) | 24/68 (35.3%) (27.5–43.1) | NS |
| Miscarriage | 4/34 (11.8%) (7.0–16.0) | 8/24 (33.3%) (25.6–40.9) | NS |
| Live birth | 30/118 (25.4%) (18.9–31.9) | 16/68 (23.5%) (16.6–30.4) | NS |
| Clinical pregnancy/cycle | 34/74 (45.9%) (38.5–53.3) | 24/43 (55.8%) (47.7–63.9) | NS |
| Live birth/cycle | 30/74 (40.5%) (33.2–47.8) | 16/43 (37.2%) (29.4–45.0) | NS |
| Number of analysed blastocysts | 307 | 191 | |
| Euploid blastocysts | 141 (45.9%) (40.3–51.1) | 82 (42.9%) (35.9–49.9) | NS |
| Aneuploid blastocysts | 155 (50.5%) (44.8–56.0) | 108 (56.5%) (49.5–63.5) | NS |
| Mosaic blastocysts | 11 (3.6%) (1.5–5.7) | 1 (0.5%) (0.1–0.8) | 0.03 |